July/August 2022 - Pharmaceutical Market Europe

July/August 2022 - Pharmaceutical Market Europe
Published on 20 July 2022

Description:

Celebrating this year’s Communiqué Awards; comms excellence – targeting the right channel at the right time; pharma’s environmental commitments

Preview:

33 articles from this collection:
PME April 2022
PME April 2022
2 - T40
2 - T40
3 - Comment
3 - Comment
4 - PMLIVE
4 - PMLIVE
5 - Contents
5 - Contents
6-7 - News
6-7 - News
6-7 - PME - Pharma Market Europe Pharmaceutical News
8-9 - News
8-9 - News
10-11 - Coronavirus news
10-11 - Coronavirus news
12 - DARWIN'S MEDICINE - Born strategic – why great  strategists are both born and made
12 - DARWIN'S MEDICINE - Born strategic – why great strategists are both born and made
12 - Pharma Market Europe Darwin’s medicine
13 - POLICY AND PUBLIC HEALTH - My body. My choice. Are we all  talking about the same thing?
13 - POLICY AND PUBLIC HEALTH - My body. My choice. Are we all talking about the same thing?
The technology responses to this pandemic have fallen far short of expectations
14 - MIKE DIXON - That ‘don’t’ impress me much
14 - MIKE DIXON - That ‘don’t’ impress me much
15 - PHARMA STARTEGISTS’ BLOG - Are we the masters or servants  of omnichannel engagement?
15 - PHARMA STARTEGISTS’ BLOG - Are we the masters or servants of omnichannel engagement?
16-17 - SUSTAINABILITY IN PHARMA - Environment: where does the pharmaceutical industry stand?
16-17 - SUSTAINABILITY IN PHARMA - Environment: where does the pharmaceutical industry stand?
18-19 - TL HANOVER - Transforming clinical trials to accelerate drug development
18-19 - TL HANOVER - Transforming clinical trials to accelerate drug development
20-21 - UK SCIENCE INNOVATION: How the Royal Society’s EiR programme can help to drive UK innovation
20-21 - UK SCIENCE INNOVATION: How the Royal Society’s EiR programme can help to drive UK innovation
22-23 - AI AND PHARMA: AI: powering healthcare, empowering patients
22-23 - AI AND PHARMA: AI: powering healthcare, empowering patients
24-29 - COMMUNIQUE AWARDS 2022
24-29 - COMMUNIQUE AWARDS 2022
30 - TL - The patient voice – the value of patient-reported outcomes in HTA
30 - TL - The patient voice – the value of patient-reported outcomes in HTA
31 - MARKETING & COMMS HIGHLIGHTS
31 - MARKETING & COMMS HIGHLIGHTS
32-34 - COMMS EXCELLENCE - Achieving communication excellence by targeting the right channel at the right time
32-34 - COMMS EXCELLENCE - Achieving communication excellence by targeting the right channel at the right time
35 - EBR
35 - EBR
36 - TL PURPLE AGENCY - ‘Who moved my cheese?’  The impact of COVID-19 on communications excellence
36 - TL PURPLE AGENCY - ‘Who moved my cheese?’ The impact of COVID-19 on communications excellence
37 - SAMEDAN
37 - SAMEDAN
38-39 - CANNES LIONS - Cannes Lions shows health creative is becoming an art form
38-39 - CANNES LIONS - Cannes Lions shows health creative is becoming an art form
40-41 - STRATEGIC COMMITMENT - Strategic commitment
40-41 - STRATEGIC COMMITMENT - Strategic commitment
42 - TL IPSEN - Innovation through collaboration – the importance of partnerships
42 - TL IPSEN - Innovation through collaboration – the importance of partnerships
43 - FLYPHARMA
43 - FLYPHARMA
44-45 - FLYPHARMA EUROPE - Environment: where does the pharmaceutical industry stand?
44-45 - FLYPHARMA EUROPE - Environment: where does the pharmaceutical industry stand?
46-48 - Appointments
46-48 - Appointments
49 -  HEALTHCARE COMMS
49 - HEALTHCARE COMMS
50 -  RESEARCH - The NHS is awarded the George Cross, UK’s highest civilian gallantry award, for its service during the COVID-19 pandemic
50 - RESEARCH - The NHS is awarded the George Cross, UK’s highest civilian gallantry award, for its service during the COVID-19 pandemic
51 - Recruitment
51 - Recruitment
43 - Pharma Market Europe (PME) Recruitment
52 - RESEARCH PARTNERSHIP
52 - RESEARCH PARTNERSHIP